Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production
Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production Thermo Fisher Scientific Inc. the world leader in serving science, today announced more than $600 million in capital investments to expand its bioprocessing production capabilities through 2022. These investments are expected to more than double the company’s current manufacturing capacity and support biopharma customers as they ramp up to meet both the short-term demands related to COVID-19 as well as long-term … Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today ann...
Source: investingnews.com